Panel Interview of ONcology practices with Emergent Experience of teclistamab in the Real world: the TecPIONEER Study

Objective To understand providers' current teclistamab step-up dosing (SUD) model and how they envision future administration models, as well as perceived barriers and facilitators to these models in day-to-day clinical practice.